Urine Metabolites in the Diagnosis of Disease
Luventix, Inc. · NCT06710067
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1250
- US sites recruiting
- 4
- Study start
- October 1, 2024
- Record last updated
- December 13, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this observational study is to validate a non-invasive, urine-based diagnostic technology for the detection and differentiation of various gastrointestinal (GI) diseases.
This research study intends to enroll participants across a range of demographics and GI disease states including colorectal cancer, small intestinal bacterial overgrowth (SIBO), Crohn\'s disease, and Celiac disease, collect urine samples and clinical data, and use artificial intelligence and machine learning to build disease-specific models which can identify and differentiate a participants' specific GI disease.
The main questions it aims to answer are
- Does the platform identify a disease signal within each disease cohort, compared to normal controls?
- How well does the test perform (e.g. sensitivity and specificity/false-positive rate)?
Conditions: Colorectal Cancer; Small Intestinal Bacterial Overgrowth Syndrome (SIBO); Crohn Disease; Celiac Disease
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age ≥ 18 years of age at time of enrollment.
- Able and willing to provide a one-time urine sample and comply with all study procedures for the study.
- Able to understand the study procedures, able to provide consent to participate in the study, and willing to authorize release of relevant protected health information by consenting to a HIPAA medical release form.
Exclusion Criteria
- Known to be pregnant.
- A medical condition which, in the opinion of the Investigator and/or Sponsor, should preclude enrollment in the study.
Recruiting US locations
Unio Health Partners (Gastroenterology)
Encinitas, CA 92024
Site contact: Sarah Marchetti, Practice Manager · 760-783-0441 · sarah.marchetti@uniohp.com
Digestive Health Associates
Santa Monica, CA 90404
Site contact: La Juana, Study Coordinator · 310-829-6789 · elle20124me@gmail.com
Westside Gastro Care
Santa Monica, CA 90404
Site contact: Jennifer, Patient Care Coordinator · 310-285-3005 · execassistant@westsidegastrocare.com
Bass Medical Group (Gastroenterology)
Walnut Creek, CA 94598
Site contact: Stephanie Saxton, Practice Manager, CMA · 925-329-3723 · stephanie.saxton@bassmedicalgroup.com
Study contacts (from the official record)
- Catherine Fine, MS, CGC · 888-404-3143 · research@luventix.com
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55